Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo.
NYZL1 may represent a lead peptide structure.
»
01/13/16
Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis.
Afatinib was more effective than erlotinib as second-line treatment of patients.
»
07/28/16
Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.
Study identified potential new therapeutic targets for mucosal melanoma.
»
03/16/17
Effect of green tea catechins on gastric mucosal dysplasia in insulin-gastrin mice.
GTCs may play a protective role in the development of gastritis and pre-malignant lesions.
»
12/22/15
Homeobox B9 mediates resistance to anti-VEGF therapy in colorectal cancer patients.
Patients affected by an HOXB9-negative tumor had a significantly longer PFS.
»
03/08/17
Breast cancer subtype distribution is different in normal weight, overweight, and obese women.
Obese and overweight women were more likely to present with TNBC.
»
03/06/17
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
Dasatinib response rate among KIT+ melanoma patients was low.
»
01/08/17
Vascular-Targeted Photodynamic Therapy with Padeliporfin for Low Risk Prostate Cancer Treatment: Mid-Term Oncological Outcomes.
Median PSA decreased significantly by 41% six months post-treatment and remained stable.
»
03/12/17
Regression and Progression Predictors of CIN2 in Women Younger Than 25 Years.
The hazard ratio for time to progression was 2.40 for women who smoked.
»
05/21/16
Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
L35P established as the first pathogenic missense mutation in PALB2.
»
09/26/16
< Prev
Next >